Viral Hepatitis Elimination and Control Program - Albania (National program)

Viral Hepatitis Elimination and Control Program - Albania (National program)

Virus targets
Hepatitis B
Hepatitis C
Operational research
Testing and treatment implementation
Other targets
Health outcomes
WHO region
European Region
Key interventions
Blood safety
Hepatitis B Vaccination
Injection safety and infection control
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Prevention mother-child transmission
Strategic data analysis
Screening and diagnosis
Treatment (direct or referral)
Target population
Adolescents (10 - 19 years of age)
All ages
Birth cohorts of adults
Blood transfusion recipients
Children (> one year < 10 years of age)
Household contact(s)
Incarcerated populations (current and former)
Infants (less than one year of age)
Men who have sex with men
Newborn (born in last 30 days)
Occupations with possible exposure
Persons who inject drugs
Pregnant women
Performance target
Blood safety
Care cascade: Evidence of current infection
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Care cascade: Referred for treatment
Harm reduction (access to safe injection equipment for persons who inject drugs)
HBV prevention of mother to child transmission
Hepatitis B vaccination coverage
Injection safety
If you would like to have a program page for your program, please create an account and submit program information here

Health outcomes additional info

Incidence near to 0 of Hepatitis B to children until 18 years old by 2021, 80% reduction of incidence at pregnant women 2023, 50% reduction of prevalence in risk groups by 2023


Performance target additional info

98% coverage of Hepatitis B vaccination of newborns, 75% coverage of pregnant women tested and followed up, 100% of all blood tested for Hepatitis B and C etc, and 0 infections transmitted from blood transfusion, 80% coverage of access to safe equipment for people who inject drugs, HBV and HCV testing and diagnosis access to 70% of the risk population, 70% of people who need it are referred to treatment and receiving it for Hepatitis B and C.

Summary and objectives

1. Improvement of surveillance of acute Hepatitis and establishment of Chronic Hepatitis surveillance,, testing and early detection of Viral Hepatitis

2. Improvement of treatment and care to prevent harms and liver cancer and treatment as prevention

3. Improvement of education heath care workers and communities to understand and prevent Viral Hepatitis

4. Viral Hepatitis B elimination in children, adolescents and youngsters

5. Reduction of i ViralHepatitis in injecting drug users

6. Protection of health care workers and other risk groups from Viral Hepatitis related to health care

7. Establish an environment with effective policies and regulations to prevent Viral Hepatitis in every level of health care

Last updated